Despite its widespread use in agriculture, data about cyanamide-induced genotoxicity are scanty, and its genotoxic potential was considered equivocal in vitro. Hence, the current study was carried out to evaluate the in vivo genotoxic potential of hydrogen cyanamide to complement the earlier in vitro research work. Thirty adult male rats were randomly assigned into 3 equal groups. Group I rats served as a control. Animals of groups II and III received hydrogen cyanamide in a dose of 10 and 20 mg/kg body weight/day respectively. All animals were treated by oral gavage, once daily, for 28 days. As end points, chromosomal aberrations, micronucleated polychromatic erythrocytes, mitotic index and polychromatic/normochromatic cell ratio in the animals' bone marrow cells were analyzed. Negative results were obtained regarding the presence of chromosome aberrations and micronuclei in each of the lowdose and high-dose cyanamide-treated rats compared to the controls. Also, cyanamide treatment did not reduce the mitotic index or polychromatic/normochromatic cell ratio in the exposed animals. This study found that hydrogen cyanamide exposure had no genotoxic potential in rat bone marrow cells in the doses used and under the conditions of the performed assays.
INTRODUCTION
Safety standards consider the product as highly toxic with rat oral LD 50 of 125 mg/kg (Lewis and Sax, 2004). In laboratory animals cyanamide induces adverse effects in the liver, thyroid, kidneys, ovaries and testes, and it has the potential to cause similar effects in humans. These adverse effects were identified in sub-chronic toxicity, chronic toxicity and oncogenicity studies (Grant, 1986; Proctor et al., 1996; Sheshadri et al., 2011).
Human acute cyanamide exposure has been associated with dizziness, nausea, vomiting, heartburn, dyspnea, tachycardia and severe irritation and ulceration of the skin, conjunctiva and respiratory tract mucosa Ramel, 1980) . Hence, the current study was carried out using both the sensitive CA technique and the MN assay for evaluation of genome damage induced by hydrogen cyanamide in the rat bone marrow cells to complement the earlier in vitro genotoxicity research work.
MATERIALS & METHODS

Chemicals:
Hydrogen cyanamide was purchased from a local commercial source. All other chemicals used in the study were of the highest purity available, and were obtained from ElNasr, Pharmaceutical Chemicals Company (Cairo, Egypt).
Compliance with ethical standards:
The Research Ethics Committee of Tanta Faculty of Medicine approved the study protocol. The current study was carried out on 30 adult male albino rats with average body weight of 200±20 gm. They were housed in clean, properly ventilated cages (five rats in each cage), under standard environmental conditions of lighting (12 h light/dark cycles) and temperature (23±2 ºC), with free access to food and water throughout the experiment. They were acclimatized to their environment two weeks before starting the experiment.
Experimental design:
The animals were randomly assigned into 3groups (10 rats each). Group I animals served as a control. Animals of groups II (low-dose group) and III (high-dose group) received hydrogen cyanamide in a dose of 10 and 20 mg/kg body weight/day respectively. Hydrogen cyanamide was dissolved in sterile distilled water. Control animals received equivalent amounts of the vehicle. All animals were treated by oral gavage, once daily, for 28 days. The animals were examined for clinical manifestations of toxicity throughout the study. At the Egypt J. Forensic Sci. Appli. Toxicol Vol 16(2) December 2016 end of the treatment period, the rats were sacrificed 24 hours after the last dosing, dissected, their femurs removed and the bone marrow extracted.
Chromosomal aberration assay:
The animals were intraperitoneally injected with 4 mg/kg body weight colchicine 1 h prior to sacrifice to arrest the cells at metaphase. The bone marrow from each of these animals was eluted in 5 mL Hanks' Solution and centrifuged at 1000 rpm for 5 min. The pellets were suspended in 10 ml aqueous KCl (0.075 M) and incubated for 12 min at 37 °C. The cells were fixed in glacial acetic acid/methanol solution (1:3, v/v), centrifuged, washed 3 times and suspended in a small volume of the fixative. The fixed cells were smeared onto clean glass slides and air-dried. Slides were washed 3 times with purified water, stained with Giemsa for 15 min, rinsed, air-dried and mounted with cover slips. The slides were coded before analysis in a blind manner. Metaphases containing between 40 and 44 chromosomes were accepted for scoring. For each animal, a total of 100 well-spread metaphases were screened for CA. The mitotic index (percentage of cells in mitosis) was scored in 1000 cells per animal as an indicator of cytotoxic activity (Kirkland et al., 2015) .
Micronucleus assay:
The marrow flushed out from the bones was collected with 3 ml of fetal bovine serum and centrifuged at 1000 rpm for 5 min. The serum was discarded and the pellet was spread onto a clean glass slide and air-dried. The slides were stained with Giemsa, mounted with cover slips and coded before analysis in a blind manner. For each animal, a total of 2000 polychromatic erythrocytes (PCE) were analyzed for the frequency of micronuclei. Toxicity to bone marrow was assessed by scoring a total of 1000 erythrocytes per animal to determine the ratio of PCE to normochromatic erythrocytes (NCE) (Kirkland et al., 2015) .
Statistical analysis: Statistical analysis was performed using the Statistical Package for Social Sciences for Windows (SPSS Inc., Chicago, IL, USA, Version 16.0). The results were recorded as mean and standard deviation for each group, and then the differences between the treated groups and the controls were statistically evaluated using one-way analysis of variance (ANOVA) test. p≤0.05 was considered statistically significant.
RESULTS
No mortalities occurred in the control or the cyanamide-treated groups, and all animals remained healthy until the harvest timepoint. Aberrations in the form of gaps, breaks, fragments and dicentric chromosomes were evident (Figs. 1-3) . The frequencies of aberrant cells in any of the cyanamide-treated groups were not significantly different from that of the control group. The frequencies of micronucleated PCE from both the low-dose and high-dose cyanamidetreated animals did not differ significantly from that observed in the control group. Also, animal treatment with 10 and 20 mg/kg body weight/day cyanamide was not cytotoxic to the bone marrow, since it had no significant effect on mitotic index and did not significantly reduce the PCE:NCE ratio in exposed animals compared to their respective controls (Table 1) (Ivett 1987, unpublished study) . Hence, the current study was conducted to evaluate the in vivo genotoxic potential of hydrogen cyanamide using the sensitive CA technique in addition to the MN assay, which enables both chromosome breakage and loss to be measured reliably.
Actual exposure conditions take place either during cyanamide production or application to plants or during consumption of cyanamidecontaminated products. These conditions arise from exposure to small doses for long period. Therefore, in a trial to simulate actual exposure conditions for consumers of cyanamide-contaminated products, relatively small doses (10 and 20 mg/kg body weight/day) were used via the oral route for longer duration of exposure. Such difference in both dose and duration make this work rational as well as other comparable studies (Menargues et al., 1984) .
The present study found no significant increase in the frequencies of aberrant cells or micronucleated PCE in cyanamide-treated animals compared to their respective controls. Animals treated with cyanamide did not show significant changes in mitotic index or the PCE:NCE ratio, reflecting the absence of cytotoxic effect on the bone marrow. These results indicate that under the exposure conditions evaluated and for the calculated power of the study, cyanamide exposure did not result in a significant increase in genome damage in the cell population 
CONCLUSIONS
Evaluation of DNA damage using different genotoxicity testing techniques has been considered as an essential step to understand carcinogenesis and assess the risk of cancer incidence. The results obtained in this study, as well as scanty studies by other authors, point to lack of clastogenic and aneugenic activity of hydrogen cyanamide under the conditions of these assays. However, research work using longer durations of exposure and different species of test animals, in addition to assessment of exposed individuals, taking into consideration the intensity, duration and pattern of exposure, are mandatory for comprehensive evaluation of cyanamide mutagenic potential. 
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